Results 101 to 110 of about 36,879 (249)

Capturing the late complications of venous thromboembolism

open access: yesResearch and Practice in Thrombosis and Haemostasis
A state-of-the-art lecture titled “Capturing the late complications of venous thromboembolism: the role of patient-reported outcomes” was presented at the International Society on Thrombosis and Haemostasis (ISTH) Congress 2025 in Washington, DC. Venous thromboembolism (VTE) is increasingly recognized as a chronic condition with substantial long-term ...
Højen, Anette Arbjerg   +4 more
openaire   +3 more sources

Rotational Thromboelastometry Findings Are Associated with Symptomatic Venous Thromboembolic Complications after Hip Fracture Surgery. [PDF]

open access: yesClin Orthop Relat Res, 2021
Tsantes AG   +12 more
europepmc   +1 more source

Human brain matters: Navigating the neuropathology of COVID‐19

open access: yesBrain Pathology, EarlyView.
Severe COVID‐19 is associated with vascular dysregulation and chronic neuroinflammation, leading to axonal injury and neurodegeneration. In long COVID or PASC, persistent alterations in neuroimaging and biofluid biomarkers reflect ongoing neuronal damage and neuroinflammation, contributing to long‐term neurological symptoms including fatigue, cognitive
Juliana M. Nieuwland   +4 more
wiley   +1 more source

VENOUS INSUFFICIENCY AND THROMBOEMBOLIC DISEASE IN BARIATRIC SURGERY PATIENTS [PDF]

open access: yes, 2013
Context Morbid obesity is associated with various co-morbidities, including chronic venous insufficiency. Bariatric surgery is the only effective treatment for morbid obesity, but with potential risks and possible complications, including venous ...
Bonno van BELLEN   +3 more
core   +1 more source

Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley   +1 more source

Prevention and Management of Venous Thromboembolic Disease in Cushing’s Syndrome: A Proposal based on a Case Report and Literature Review

open access: yesIatreia
Introduction: Cushing’s syndrome is associated with multiple complications, among which thromboembolic disease is relatively frequent and contributes substantially to morbidity and mortality. Objectives: Conduct a review of the topic based on a clinical
Gutiérrez Restrepo, Johnayro   +2 more
doaj   +1 more source

Analysis of venous thromboembolic complications [PDF]

open access: yes, 2020
Objective: To analyze the course and outcomes of pregnancies in women of moderate and high risk groups for the development of venous thromboembolic complications (VTEС).
Киселева, Е. Ю.   +6 more
core  

Cardiotoxicity of BRAF/MEK inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Rapidly accelerated fibrosarcoma type B/B‐Raf proto‐oncogene, serine/threonine kinase (BRAF) and mitogen‐activated protein kinase (MEK) inhibitors have transformed outcomes in cancer therapy, particularly in melanoma. However, cardiovascular toxicities are increasingly recognized in real‐world clinical practice.
Katharina Seuthe   +4 more
wiley   +1 more source

A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients

open access: yesBMC Infectious Diseases
Thromboembolic (TE) complications [myocardial infarction (MI), stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE)] are common causes of mortality in hospitalised COVID-19 patients.
Hanies Yuhana Othman   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy